Loading clinical trials...
Loading clinical trials...
A Phase 2, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Filgotinib in Subjects With Active Noninfectious Uveitis
Conditions
Interventions
Filgotinib
Placebo to match filgotinib
+1 more
Locations
24
United States
Stanford Byers Eye Institute
Palo Alto, California, United States
Colorado Retina Associates PC
Golden, Colorado, United States
Northwestern Medical Group
Chicago, Illinois, United States
Illinois Retina Associates
Oak Park, Illinois, United States
Ophthalmic Consultants of Boston
Boston, Massachusetts, United States
Associated Retinal Consultants PC
Royal Oak, Michigan, United States
Start Date
July 26, 2017
Primary Completion Date
December 29, 2020
Completion Date
April 22, 2021
Last Updated
January 21, 2022
Lead Sponsor
Gilead Sciences
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions